Avian Influenza (Infectious Disease) Drugs in Development, 2021 Report - ResearchAndMarkets.com

b'The "Avian Influenza (Infectious Disease) - Drugs in Development, 2021" report has been added to ResearchAndMarkets.com\'s offering.\nThe report provides comprehensive information on the therapeutics under development for Avian Influenza, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type.\nThe report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases.

Metadata
Provider: 
Business Wire, Inc.Business Wire, Inc.
Retrieved on: 
Wednesday, April 28, 2021
Information
Tags: 
Infectious diseases, Pharmaceutical, Health, Animal virology, Agricultural health and safety, Avian influenza, Veterinary medicine, Influenza, Medical specialties, Health sciences
⚠generated by AI ↴
Summary
Key Points: 
  • b'The "Avian Influenza (Infectious Disease) - Drugs in Development, 2021" report has been added to ResearchAndMarkets.com\'s offering.\nThe report provides comprehensive information on the therapeutics under development for Avian Influenza, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type.\nThe report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases.
  • Additionally, the report provides an overview of key players involved in therapeutic development for Avian Influenza and features dormant and discontinued projects.\nThe report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.\nThe report reviews pipeline therapeutics for Avian Influenza (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.\nThe report covers pipeline products based on various stages of development ranging from discovery till pre-registration.\nThe report features descriptive drug profiles for the pipeline products which includes, Product Description, Descriptive MoA, R&D Brief, Licensing and Collaboration details & Other Developmental Activities.\nThe report reviews key players involved in the development of Avian Influenza (Infectious Disease) therapeutics and enlists all their major and minor projects.\nThe report assesses Avian Influenza (Infectious Disease) therapeutics based on Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type.\nThe report summarizes all the dormant and discontinued pipeline projects.\n'


The "Avian Influenza (Infectious Disease) - Drugs in Development, 2021" report has been added to ResearchAndMarkets.com's offering.

The report provides comprehensive information on the therapeutics under development for Avian Influenza, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type.

The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Avian Influenza and features dormant and discontinued projects.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Scope

  • The report provides a snapshot of the Global Therapeutic Landscape of Avian Influenza (Infectious Disease).
  • The report reviews pipeline therapeutics for Avian Influenza (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The report covers pipeline products based on various stages of development ranging from discovery till pre-registration.
  • The report features descriptive drug profiles for the pipeline products which includes, Product Description, Descriptive MoA, R&D Brief, Licensing and Collaboration details & Other Developmental Activities.
  • The report reviews key players involved in the development of Avian Influenza (Infectious Disease) therapeutics and enlists all their major and minor projects.
  • The report assesses Avian Influenza (Infectious Disease) therapeutics based on Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type.
  • The report summarizes all the dormant and discontinued pipeline projects.
  • The report reviews latest news related to pipeline therapeutics for Avian Influenza (Infectious Disease).

Key Topics Covered:

  • Introduction
  • Report Coverage
  • Indication - Overview
  • Indication - Therapeutics Development
  • Pipeline Overview
  • Pipeline by Companies
  • Pipeline by Universities/Institutes
  • Products under Development by Companies
  • Products under Development by Universities/Institutes
  • Indication - Therapeutics Assessment
  • Assessment by Target
  • Assessment by Mechanism of Action
  • Assessment by Route of Administration
  • Assessment by Molecule Type
  • Indication - Companies Involved in Therapeutics Development
  • Indication - Drug Profiles
  • Indication - Dormant Projects
  • Indication - Discontinued Products
  • Indication - Product Development Milestones
  • Featured News & Press Releases
  • Appendix

For more information about this report visit https://www.researchandmarkets.com/r/n98ooy

Copyright: 
Copyright Business Wire 2021